期刊文献+

人类免疫缺陷病毒合并丙型肝炎病毒双重感染的研究进展 被引量:1

暂未订购
导出
摘要 随着高效抗反转录病毒治疗(high active anfi-retroviral therapy,HAART) 的广泛应用,人类免疫缺陷病毒 (human immunodeficiency virus, HIV ) /丙型肝炎病毒(hepattis Cvirus,HCV)感染者的预后得到了显著改善,然而随着患者寿命的延长,其合并的HCV感染对患者的病死率有很大影响。终末期HCV相关性肝病是HIV感染导致死亡的主要原因之一。
出处 《中国医师进修杂志(内科版)》 2009年第10期76-78,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献21

  • 1Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol, 2008, 23 (7): 1000-1008.
  • 2刘震,邢文革,张永宏,张麒,龙小山,张桂云,吴昊,蒋岩.既往有偿献血(浆)人群中艾滋病毒与丙型肝炎病毒共感染研究[J].中华肝脏病杂志,2006,14(6):464-465. 被引量:36
  • 3尹春煜,卢洪洲,娄国强,李晓鸥,蒋卫民,胡越凯,张继明,潘孝彰,翁心华.中国部分地区应用高效抗逆转录病毒治疗HIV-1患者的耐药性检测[J].中华传染病杂志,2006,24(3):164-167. 被引量:23
  • 4李林,鲍作义,隋洪帅,刘思扬,庄道民,刘永健,苗文泉,李珏,李敬云.我国部分地区HIV感染者HCV协同感染状况的调查研究[J].中国艾滋病性病,2008,14(1):9-11. 被引量:34
  • 5项小培,李兴旺,徐克沂.艾滋病治疗学.合肥:安徽科学技术出版社,2007:301-304.
  • 6de L e dinghen V, Barreiro P, Foucher J, et al. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat, 2008, 15 (6) :427-433.
  • 7Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Deficsyndr, 2001,26(4) : 340-344.
  • 8Ranch A, Gaudieri S, Evison J, et al. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antivir Ther, 2008,13 (3):455-460.
  • 9Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.Clin Infect Dis, 2002, 34(6) : 831-837.
  • 10Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr, 2001,26(5 ) : 466-472.

二级参考文献20

  • 1Mohsen AH,Easterbrook P,Taylor CB,et al.Hepatitis C and HIV-1 coinfection.Gut,2002,51:601-608.
  • 2Dusheiko G,Schmilovitzweiss H,Brown D,et al.Hepatitis C virus genotypes:an investigation of type-specific difference in geographic origin and disease.Hepatology,1994,19:13-18.
  • 3Bonacini M,Govindarajan S,Blatt LM,et al.Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.J Viral Hepat,1999,6:203-208.
  • 4Pillay D,Taylor S,Richman DD.Incidence and impact of re sistance against approved antiretroviral drugs.Rev Med Virol,2000,10:231-253.
  • 5Susman E.Many HIV patients carry mutated drug-resistant strains.Lancet,2002,359:49.
  • 6Little SJ,Holte S,Routy JP,et al.Antiretroviral-drug resistance among patients recently infected with HIV.N Engl J Med,2002,347:385-394.
  • 7Whitcomb JM,Parkin NT,Chappey C,et al.Broad nucleoside reverse transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.J Infect Dis,2003,188:992-1000.
  • 8Calvez V,Costagliola D,Descamps D,et al.Impact of stavu dine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.Antivir Ther,2002,7:211-218.
  • 9Huang W,Gamarnik A,Limoli K,et al.Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.J Virol,2003,77:1512-1523.
  • 10Klimkait T,Vernazza P.Adherence and resistance.Ther Umsch,2004,61:631-634.

共引文献75

同被引文献7

  • 1Westland CE, Yang H, Delaney WE, et al. Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients. J Viral Hepat, 2005, 12( 1 ) : 67-73.
  • 2Peters MG, Harm HW, Martin P, et al. Adefovir dipivoxil done or in combination with camirudine in patients with lamivudine ivudine resistant chronic hepatitis B. Gastroenterology, 2004, 126( 1 ) : 91- 101.
  • 3Perrillo R, Hann HW, Mutimer D, et al. Adefovir dipivoxil added to ongoing Lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology, 2004, 126( 1 ) : 81-90.
  • 4Chiang LC, Ng LT, Liu LT, et al. Cytotoxieity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med, 2003, 69(8): 705-709.
  • 5姚海云,房桂青,韩雪莹.丙肝患者血清HCV RNA定量与抗-HCV检测效果分析[J].中国输血杂志,2008,21(7):535-536. 被引量:9
  • 6熊春林,郭满盈,罗媛烨,杨海燕.丙肝抗体阳性者血清中HCV抗原的检测[J].实验与检验医学,2009,27(3):320-320. 被引量:13
  • 7陈丽霞,姚履枫,韩荔芬,郑磊,徐庆玲.慢性乙型肝炎孕妇HBVDNA定量与肝功能的关系[J].中国基层医药,2011,18(17):2414-2415. 被引量:4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部